SEC Filings - Arcutis Biotherapeutics

Filing date	Description	Form	View
Jan 30, 2020	Initial filing by director officer or owner of more than ten percent.	3	0001209191-20-005691.pdf 0001209191-20-005691.rtf 0001209191-20-005691.xls View HTML
Jan 30, 2020	Initial filing by director officer or owner of more than ten percent.	3	0000899243-20-002371.pdf 0000899243-20-002371.rtf 0000899243-20-002371.xls View HTML
Jan 30, 2020	EFFECT	EFFECT	9999999995-20-000198.pdf 9999999995-20-000198.rtf 9999999995-20-000198.xls View HTML
Jan 28, 2020	CORRESP	CORRESP	0001193125-20-016868.pdf 0001193125-20-016868.rtf 0001193125-20-016868.xls View HTML
Jan 28, 2020	CORRESP	CORRESP	0001193125-20-016867.pdf 0001193125-20-016867.rtf View HTML
Jan 21, 2020	Amended Registration statement for face-amount certificate companies	S-1/A	0001193125-20-010664.pdf 0001193125-20-010664.rtf 0001193125-20-010664.xls View HTML
Jan 21, 2020	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	0001193125-20-011069.pdf 0001193125-20-011069.rtf 0001193125-20-011069.xls View HTML
Jan 13, 2020	CORRESP	CORRESP	0001193125-20-006564.pdf 0001193125-20-006564.rtf 0001193125-20-006564.xls View HTML
Jan 06, 2020	Registration statement for face-amount certificate companies	S-1	0001193125-20-001990.pdf 0001193125-20-001990.rtf 0001193125-20-001990.xls View HTML
Dec 13, 2019	mendment to a previously filed DRS	DRS/A	0000950123-19-011884.pdf 0000950123-19-011884.rtf 0000950123-19-011884.xls View HTML

Data provided by Kaleidoscope.